HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

polyvalent melanoma cell vaccine

a highly immunogenic preparation consisting of irradiated cells from 3 human melanoma lines
Also Known As:
CancerVax; PMCV (vaccine); polyvalent MCV
Networked: 22 relevant articles (5 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Morton, Donald L: 5 articles (10/2004 - 06/2002)
2. Morton, D L: 4 articles (01/2004 - 04/2001)
3. Essner, Richard: 4 articles (01/2003 - 06/2002)
4. Hsueh, Eddy C: 3 articles (10/2004 - 06/2002)
5. Foshag, Leland J: 3 articles (12/2002 - 06/2002)
6. Ye, Xing: 2 articles (10/2004 - 12/2002)
7. Gupta, Rishab K: 2 articles (01/2003 - 08/2002)
8. Ye, Wei: 2 articles (01/2003 - 06/2002)
9. Stern, Stacey L: 2 articles (12/2002 - 08/2002)
10. O'Day, Steven J: 2 articles (12/2002 - 08/2002)

Related Diseases

1. Melanoma (Melanoma, Malignant)
2. Neoplasms (Cancer)
3. Neoplasm Metastasis (Metastasis)
4. Hypopigmentation (Hypomelanosis)
5. Colonic Neoplasms (Colon Cancer)

Related Drugs and Biologics

1. polyvalent melanoma cell vaccine
2. Canvaxin
3. Biological Markers (Surrogate Marker)
4. Antigen-Antibody Complex (Immune Complex)
5. Vaccines
6. Melacine
7. Antigens
8. Immunoglobulin G (IgG)
9. Glycoproteins (Glycoprotein)
10. Antibodies

Related Therapies and Procedures

1. Immunotherapy